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ABSTRACT
PURPOSE: To study the functional behavior of the allograft with immunosuppression of pancreatic islets in the spleen.
METHODS: Five groups of 10 Mongrel dogs were used: Group A (control) underwent biochemical tests; Group B underwent total
pancreatectomy; Group C underwent total pancreatectomy and pancreatic islet autotransplant in the spleen; Group D underwent pancreatic
islet allograft in the spleen without immunosuppressive therapy; Group E underwent pancreatic islet allograft in the spleen and
immunosuppression with cyclosporine. All of the animals with grafts received pancreatic islets prepared by the mechanical-enzymatic
method - stationary collagenase digestion and purification with dextran discontinuous density gradient, implanted in the spleen.
RESULTS: The animals with autotransplant and those with allografts with immunosuppression that became normoglycemic showed
altered results of intravenous tolerance glucose (p < 0.001) and peripheral and splenic vein plasmatic insulin levels were significantly
lower (p < 0.001) in animals that had allografts with immunosuppression than in those with just autotransplants.
CONCLUSIONS: In the animals with immunosupression with cyclosporine subjected to allograft of pancreatic islets prepared with
the mechanical-enzymatic preparation method (stationary collagenase digestion and purification with dextran discontinuous density
gradient), the production of insulin is decreased and the response to intravenous glucose is altered.
Key words: Islets of Langerhans Transplantation. Diabetes Mellitus, Experimental. Animal Experimentation. Dogs.
RESUMO
OBJETIVO: Avaliar o comportamento funcional do alotransplante com imunossupressão de ilhotas pancreáticas no baço.
MÉTODOS: Foram utilizados cinco grupos de 10 cães mestiços: grupo A (controle) submetido aos exames bioquímicos; grupo B,
submetido à pancreatectomia total; grupo C (autotransplante) submetido à pancreatectomia total e autotransplantação de ilhotas
pancreáticas no baço; grupo D, submetido à alotransplantação de ilhotas pancreáticas no baço sem terapia imunossupressiva; grupo E,
submetido à alotransplantação de ilhotas no baço e imunossupressão com ciclosporina.  Todos os animais transplantados receberam
ilhotas pancreáticas isoladas pelo método mecânico-enzimático, digestão estacionária com colagenase e purificação com gradiente de
densidade descontínua de dextran e foram implantadas no baço.
RESULTADOS: Animais autotransplantados e alotransplantados com imunossupressão que se tornaram normoglicêmicos apresentaram
testes de tolerância à glicose intravenosa alterados (p<0,001) e o nível de insulina plasmática periférica e na veia esplênica foram
significantemente menores (p<0,001) nos animais alotransplantados com imunossupressão em relação aos autotransplantados.
CONCLUSÃO: Nos animais submetidos ao alotransplante de ilhotas pancreáticas com imunossupressão com ciclosporina e preparadas
pelo método mecânico-enzimático, digestão estacionária com colagenase e purificação com gradiente de densidade descontínua de
dextran, a produção de insulina está diminuída e a resposta à sobrecarga de glicose intravenosa alterada.
Descritores: Transplante das Ilhotas Pancreáticas. Diabetes Mellitus Experimental. Experimentação Animal. Cães.
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Introduction
Diabetes mellitus is the major cause of neuropathy,
amputation and impotence in the Western hemisphere and is one
of the main chronic debilitating childhood diseases1. It is estimated
that 4% of the worldwide adult population is a carrier of diabetes
mellitus, 10% of them with type 1 or juvenile diabetes1.
Even with satisfactory results, pancreatic transplant is an
involved operation, not without potentially serious complications1.
In this sense, the transplant of pancreatic islets is an attractive
alternative as it is a minor procedure without the risk of potentially
serious complications observed with total pancreatic transplants1,2.
Pancreatic islet transplantation has been intensively studied as an
alternative to vascularized transplant of the pancreas3,4.
The disadvantages of pancreatic islet transplant are the
difficulty of isolating viable and functioning human islets in
sufficient quantities to maintain a normoglycemic state, and the
immunogenocide of the islets that requires considerable amounts
of immunosuppressive drugs to prevent rejection5.
However, the more compact pancreas of large mammals
yields a low number of functionally viable and isolated pancreatic
islets caused by the strong connections between their own islets
and the pancreatic exocrine tissue that surrounds them6-9.
For the clinical transplantation of pancreatic islets to be
enhanced, it is imperative that certain conditions must be assured.
First, it is necessary to create a large mammal model in which the
problems of the isolation of islets are similar to the conditions of
the human pancreas. Second, the islet transplants should have
extended follow-up to study their accommodation to the site of
ectopic implantation. Third, the response to food intake should be
studied, because it is an accurate indicator of the metabolic control
achieved with the insulin supplementation caused by to the
pancreatic islet transplantation1.
Therefore, the search for experimental models of isolation
and transplantation involving efficiency and simplification of the
procedures remains an objective to be pursued so that the clinical
transplant of pancreatic islets can become a safe and efficient
therapeutic option5.
The purpose of this study was to evaluate the functional
behavior of the allograft with immunosuppression with
cyclosporine of pancreatic islets isolated using the method of
mechanical-enzymatic preparation (stationary collagenase
digestion and with dextran discontinuous density gradient) in the
spleen of dogs.
Methods
Fifty young adult male mongrel dogs were used and they
weighed between 8 kg and 12 kg. The use of laboratory animals
follows the Council for International Organization of Medical
Sciences (CIOMS) ethical code for animal experimentation10.
The animals were divided into 5 groups, each consisting
of 10 dogs. In the control group (A), the animals were not operated
on and demonstrated normal fasting glucose values, fasting insulin
and intravenous glucose tolerance tests (IGTT). In the other groups,
all the animals underwent total pancreatectomy without
duodenectomy11. In group B, the animals underwent only a total
pancreatectomy; in group C, the animals also underwent the
autotransplant of pancreatic islet tissue in the spleen; in group D,
the animals were submitted to allograft of pancreatic islet tissue in
the spleen without immunosuppression, and in group E, the
allograft of pancreatic islet tissue in the spleen was done with
immunosuppression.
All the animals operated on had laparotomy performed
through a ventral midline incision. The main pancreatic duct was
immediately isolated before its penetration of the duodenal wall.
The preparation of the pancreatic tissue, the pancreatectomy, and
the pancreatic islet isolation procedures were performed as
previously described9,12. The degree of contamination was
measured by comparison relative to the quantity of stained islets
and of the stained acinar and non-acinar tissue (Figure 1).
FIGURE 1 - Photomicrograph of pancreatic islet (arrow) separated from the surrounding
exocrine tissue, after pancreatic tissue preparation (Hematoxilin and Eosine; X400).
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The animals in groups C, D, and E were kept under general
anesthesia, while the pancreas was subjected to procedures for
isolation and purification of pancreatic islet tissue. Upon
completion of these procedures, 3 to 4 tributary veins of the splenic
vein were isolated in the region near the splenic hilum. The veins
were partially opened from their anterior surface and catheterized
toward the spleen with a polyvinyl tube of diameter 4 Fr. Temporary
obstruction of the splenic pedicle vessels was performed using
bulldog-type vascular clamps, and maintained for 5 min after
finishing the infusion of the pancreatic islet preparation. The islet
preparation was injected through the intravenous catheters by
retrograde infusion using a similar amount for each one. After
removal of the occlusive clamps from the splenic pedicle, repair
of the peritoneal cavity was performed and then it was washed
with warm saline.
The animals in group E received intramuscular injections
of cyclosporine in an intramuscular dose of 20mg/kg/day the
evening before transplantation. In the post-transplant period, the
animals received intramuscular injections of cyclosporine is a dose
of 10 to 20mg/kg/day adjusted to maintain average blood levels
of 300ng/mL. The plasma levels of cyclosporine were determined
twice a week by radioimmunoassay. In all the animals of this group,
the cyclosporine was discontinued on the 30th day after transplant.
The method employed to determine serum cyclosporine was the
Incstar cyclo trac spserum/plasma RIA (INCSTAR Corporation,
Stillwater, Minnesota, USA).
The insulin level was determined by radioimmunoassay
using antibody anti-insulin (DSL-1600 Insulin Radioimmunoassay
Kit). The result was expressed in µUI/mL. In the animals of group
B (apancreatic), the blood samples for the insulin dosage were
collected during fasting immediately pre-operation and on the 7th
day post-pancreatectomy. In the animals of group D, the insulin
level was determined on the 14th day post operation. The insulin
dosages of the animals in groups C and E were collected
pre-operation, on the 14th and 28th day post-transplant during
the performance of the splenectomy in the animals that survived
until then. The collected blood was centrifuged at 3000 rpm and
the plasma obtained was stored in a freezer at -25ºC.
All the animals had their fasting glucose levels determined
with reagent strips and instrument readings by a spectrophotometer
glucometer (Glucometer II). In the animals of group A, the fasting
glucose was determined only once and served to obtain the normal
values. The animals in groups B and D had their glucose determined
before the operation and every 3 days. For the animals in groups
C and E, the fasting glucose was determined in the preoperative
period and every 3 days after the graft, and after the splenectomy
the determination was done daily. The glucose results were
expressed in milligrams% (mg%). Fasting normoglycemia was
defined up to a value of 150 mg%. Functional failure of the
pancreatic islet graft was considered as a fasting glucose level
greater than 200mg% for at least 2 consecutive days after the 14th
day post-transplant.
In the IGTT, glucose in the form of 50% dextrose and at
a dose of 0.5g/kg (kg of body weight) was injected through the
catheter placed in the radial vein, and blood samples were
withdrawn through the catheter in the femoral vein at 0, 10, 20,
30, 60, 90 and 120 min. In the animals of group B, the test was
performed on the 7th day post-pancreatectomy and the animals in
groups C, D and E were also subjected to IGTT on the 14th day
post-transplant.
The animals remained fasting in the immediate post-
operative period and, from the first day post-operation, were
progressively fed with water, a milk diet, and a standard diet ad
libitum. All the animals operated on received a pancreatic enzyme
concentrate. The animals in groups B, C, D, and E received
intramuscular cefoxitine (40 mg/kg) during the first 24 h.
The surviving animals from groups C and E were operated
on again at 28 days post-transplant. The vena cava below the level
of the renal veins and the splenic vein next to the spleen were
punctured to obtain blood samples for the determination of insulin
level. Next, the splenectomy was performed.
The following statistical tests were applied: analysis of
variance for repeated measures, the Tukey and de Newman-Keuls
multiple comparison test, Student t test, paired t test and analysis
of variance (ANOVA). In all the tests, a significance level of 5%
(p < 0.05) was adopted. The statistical program used was SPSS
14.0 for Windows.
Results
The mean fasting glucose levels of the animals in the
different groups are listed in Table 1. There was no significant
difference (p = 0.9) between the mean fasting glucose values for
the animals in group A and the mean pre-operation fasting glucose
values of the animals in groups B, C, D, and E (Table 1).
In the animals from group B, the fasting glucose levels
reached every 3 days starting the first post-operative day showed
that all the animals became hyperglycemic with blood glucose
levels above 150 mg%, and remained hyperglycemic until
death (Table 1). In the animals from group C, the fasting glucose
levels showed that all the dogs remained hyperglycemic until
at least the 7th day after the autotransplant. The glucose levels
from the 10th day after autotransplant showed that 6 animals
achieved normoglycemia while the other 4 remained
hyperglycemic; from the 13th day after, allograft from these
hyperglycemic animals became normoglycemic (Table 1) and
remained so until the 28th day after autotransplant. The post-
splenectomy blood glucose levels in this group of animals
showed hyperglycemic levels in all, and remained this way until
death. All of the animals in this group died between the 12th
and 17th day post-splenectomy.
In the animals from group D, the fasting glucose levels
showed hyperglycemia in all, a situation that continued until
death (Table 1). The mean levels of fasting blood glucose of
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TABLE 1 - Values of the means and respective standard deviations of the fasting glucose levels (mg%) pre-operative and
post-operative in the animals of groups B (apancreatic), C (autotransplant), D (allograft without immunosuppression) and
E (allograft with immunosuppression).
GLUCOSE (mg%) 
GROUPS   
PRE-
OPERATIVE                       POST-OPERATIVE   
    1º 4º 7º 10º 13º 
        
B M. 88.50 207.40 262.60 282.70 279.33 289.00 
 S.D. 15.81 38.38 40.80 36.56 25.85 35.04 
        
C M. 88.50 224.40 200.00 176.30 145.70 123.60 
 S.D. 15.14 19.96 25.14 23.33 19.22 12.46 
        
D M. 90.00 212.70 191.40 236.30 283.63 327.00 
 S.D. 17.66 27.61 24.82 38.42 25.18 17.72 
        
E M. 88.10 242.70 215.90 194.80 173.70 154.40 
 S.D. 15.93 23.08 25.62 23.47 21.83 21.80 
  ANOVA  p =0.9 (N.S.) p =0.03 * p<0.001* p<0.001*  p<0.001*  p<0.001*  
M. = Mean      S.D. = Standard deviation        N.S. = Not significant       * = Significant
The IGTT performed on the animals in groups B, C, D
and E (Table 2) was altered. A significant difference (p < 0.0001)
was observed between the determinations of 0, 10, 20, 30, 60, 90,
and 120 min of the IGTT and between the animals of groups A, B,
C, D, and E (p < 0.001) (Table 2).
The IGTT values at times 0, 10, 20, 30, 90, and 120
minutes for the animals in group E exhibited significant differences
(p < 0.05) when compared with the corresponding standard values
of the animals from group A. There was a significant difference
(p < 0.0001) between the mean values of fasting glucose levels at
different times of the IGTT for the animals from groups A, B, C,
D, and E (Table 2).
the animals from this group remained at hyperglycemic levels
from the first post-operative day until death on the 15th day
after transplant of the last surviving animal.
In the animals from group E, the fasting glucose levels
showed hyperglycemia in all the animals until the 10th day after
allograft (Table 1). Starting at day 13, 7 dogs achieved
normoglycemia and remained this way until day 25 post-allograft.
On the 28th day after allograft, the determination of the fasting
blood glucose level showed that 2 animals became hyperglycemic,
whereas other 2 other animals that behaved hyperglycemic since
the first day after allograft showed fasting normoglycemia. After
having the splenectomy on the 30th day post-allograft, all of the
animals from this group showed hyperglycemia beginning on the
first day and remained hyperglycemic until the death of the last
surviving animal. All of the splenectomized animals died between
the 9th and 14th day after splenectomy.
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The mean values of peripheral blood insulin in the animals
of group A was 11.39 ±1.77µU/mL and in the animals from groups
B, C, and E pre- and post-operation are listed in Table 3. There
was no significant difference (p = 0.18) between the mean values
of pre-operative peripheral blood insulin from animals of groups
B, C, D, and E.
TABLE 2 - Mean values (mg%) and the respective standard deviations of the intravenous glucose tolerance test
(IGTT), performed on the animals in groups A (control), B (apancreatic), C (autotransplant), D (allograft without
immunosuppression) and E (allograft with immunosuppression).
TIME (MINUTES) 
Groups  0 10’ 20’ 30’ 60’ 90’ 120’ 
A M. 92.00 203.60 182.80 159.10 143.40 118.40 87.20 
 S.D. 10.02 26.43 19.65 16.07 14.40 8.17 10.58 
B M. 306.20 416.60 379.10 348.50 322.10 304.10 299.70 
 S.D. 43.12 52.64 45.97 41.06 37.04 35.08 46.34 
C M. 106.50 262.50 235.00 200.20 157.30 130.90 99.70 
 S.D. 12.67 11.75 20.33 23.77 27.47 18.95 16.31 
D M. 275.25 372.75 353.25 346.00 328.25 305.75 278,. 5 
 S.D. 30.05 30.51 23.33 21.49 27.61 26.55 30.02 
E M. 157.00 258.70 257.40 227.80 200.00 179.70 142.60 
 S.D. 17.99 45.70 14.90 20.31 18.41 20.62 23.95 
 ANOVA p<0.001* p<0.001* p<0.001* p<0.001* p<0.001* p<0.001* p<0.001* 
M. = Mean * = Significant                        S.D. = Standard deviation
There was a significant difference (p < 0.001) between
the mean values of peripheral blood insulin determined on the
14th day post-transplant in the animals from groups B, C, D, and
E. The insulin levels at 14 days post-transplant in the animals from
group C were significantly (p < 0.05) higher than those in group E
(Table 3). The mean value of peripheral blood insulin determined
on the 28th day post-transplant in the animals of group C was
significantly (p < 0.001) higher than that obtained from animals in
group E.
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TABLE 3 -  Means (µU/mL) and respective standard deviations of the peripheral blood insulin levels
pre-operative and post-operative in the animals of groups B (apancreatic), C (autotransplant), D
(allograft without immunosuppression) and E (allograft with immunosuppression).
The mean values of blood insulin in the splenic vein on
the 28th day post-transplant, collected during performance of
the splenectomy on the animals of groups C and E are listed in
Table 4.
The mean value of blood insulin levels obtained in the
inferior vena cava of the animals in group C was significantly
(p < 0.001) higher than that of group E. The mean value of blood
 
GROUPS 
 
 
INSULIN LEVEL 
PRE-OPERATIVE POST-OPERATIVE 
 7º 14º  28º 
      
B 
M. 11.14 2.75   
S.D. 1.61 0.51   
      
C 
M. 12.50  7.97 6.80 
S.D. 2.04  0.69 0.90 
      
D 
M. 12.71 4.16   
S.D. 2.62 0.46   
      
E 
M. 11.24  5.98 4.99 
S.D. 1.45  1.58 0.53 
  ANOVA  p =0.18 (N.S.)  p<0.001*  p<0.001* p< 0.001*  
M. = Mean          N.S. = Not significant       S.D. = Standard deviation       * = Significant
insulin levels obtained in the splenic vein of the animals in group
C was significantly (p < 0.001) higher than in the dogs from group
E (Table 4). When the mean values of the blood insulin levels
obtained from the inferior vena cava and the splenic vein,
respectively, of the animals in groups C and E were compared, the
values obtained from the splenic vein were significantly (p < 0.001)
higher than those from the inferior vena cava (Table 4).
GROUPS  INSULIN LEVELS 
  INFERIOR VENA CAVA  SPLENIC VEIN  
C 
M. 7.26 20.69 
S.D. 1.00 4.06 
Paired t test  p<0.001* p<0.001* 
    
E 
M. 4.21 5.19 
S.D. 0.28 0.37 
Student t test  p<0.001* p<0.001* 
TABLE 4 - Mean values (µU/mL) and respective standard deviations of the insulin levels
determined in the inferior vena cava and in the splenic vein on the 28th day post-operation in
the animals of groups C (autotransplant) and E (allograft with immunosuppression).
M. = Mean                     * = Significant                    S.D. = Standard deviation
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Discussion
The mechanical manipulation represented by the
centrifuge and the transfer using pipettes, as well as the exposure
to hyperosmolar chemical substances during the purification
process of islets, can damage and fragment the islets, altering their
viability and functionality at the site of ectopic transplantation2,5,13-
15. These events may have contributed to the failure of the grafts in
the animals that were subjected to auto- and allotransplantation.
All of these technical peculiarities of preparation and
implementation of pancreatic islet transplantation imply the need
for a greater initial volume of islets to compensate for the loss of
viable islets during the many stages of the process5-7.
The inadequate mass of beta cells is considered the most
frequent non-immunological cause for the failure of allogenic
transplant of pancreatic islets5,13,14. Because the preparation of
“purified” canine islets is estimated to yield approximately 20%
of the total initial content of the intact pancreas3,5,15, it is expected
that the secretion of insulin should be significantly lower in the
animals subjected to pancreatic transplantation than in the control
animals4,5. In this study, it was found that there was a significant
reduction in the insulin levels between pre- and post-transplant in
the animals of groups C, D, and E. This reduction was attributed
to the reduction of the functionally active endocrine tissue mass
transplanted into the spleen because of the process of pancreatic
islet preparation.
We used the injection of the islet preparation by retrograde
infusion in tributary vessels of the splenic vein so that the graft
reached the splenic pulp. Studies show that the technique of
injection of islets by direct puncture of the splenic pulp through
the organ encapsulation is less efficient in comparison with the
technique of venous reflux through the branches of the splenic
vein2,14, as it was used in the present experiment.
Other authors4,5 have also observed changes in the insulin
serum levels. It was found that there is a reduction in the secretion
of insulin by the grafted pancreatic islet cells, even when fasting
normoglycemia is restored. The reduction in the islet cell mass
and the absence of the enervation of the islets in the heterotopic
location can directly contribute to hypo-insulinemia3. The reduction
in tolerance to glucose in the animals autotransplanted with
pancreatic islets is due to decreased insulin secretion response to
intravenous glucose5. In pancreatic islet autotransplantation in
dogs, the blood levels of insulin in the splenic vein show multiple
peaks accompanied by normoglycemia during the post-prandial
period5,15.
In the current study, the degree of change in the IGTT
was less in the autotransplant group and progressively greater in
the animals of the allograft with immunosuppression, allograft
without immunosuppression, and apancreatic groups. The degree
of change in IGTT showed a direct relationship with the magnitude
of insulin secretion by the islet transplant that was greater in the
animals with autotransplant and less in the animals from the
allograft with immunosuppression group. The apancreatic animals
showed low insulin levels as a function of residual pancreatic
parenchyma that was not totally removed during the performance
of the total pancreatectomy. Despite the incomplete removal of
insulin production in the apancreatic animals, they behaved
metabolically like diabetics and showed, in the post-operative
period, a clinical picture of ketoacidosis, hyperglicemia, polyuria,
polidipsia, and severe loss of body weight.
Other factors may contribute to modulating the immune
response to islet allo-antigens. When species-specific tolerance is
conferred, while when using mongrel dogs, as in the present
experiment, maximum incompatibility is involved6,7,13. In addition,
the maintenance of the spleen, or lack thereof, in the recipient
animals can cause some difference4,5. In this experiment, the
mongrel dogs used, the changes in the functionality of the
pancreatic islets derived from many stages of isolation and their
implantation in the spleen, and the spleen itself as the location for
the reception of the pancreatic islets may have contributed to the
failure to obtain normoglycemia in some of the animals from the
allograft with immunosuppression group.
The metabolic performance of the allograft during IGTT
remained similar to that of the control animals, despite the
significant decrease in the plasma insulin response. These results
are similar to the metabolic response of the islet allografts with a
single donor, purified or from pancreatic microfragments
transplanted in immunosuppressed dogs6,7,15. It is possible that the
inhibition of insulin secretion attributed to cyclosporine can be
partially circumvented by an increase in the mass of the islet cells7.
However, there is a need for a minimum critical level of
cyclosporine to prevent rejection of the islets6,7,13,15.
In the present study, the production of insulin in the
transplanted animals from the allograft with immunosuppression
group showed no significant difference between the animals in
this group, suggesting that the deleterious effect of cyclosporine
on the glucopenic efficiency of insulin may have contributed, at
least partially, to the failure to obtain normoglycemia in the 3 dogs.
The attempts to establish experimental models of
pancreatic islet allografts in large animals is considered important
and necessary, especially to improve the isolation techniques for
pancreatic islets and establishing clinical research protocols in order
to elucidate various aspects as yet undefined for pancreatic islets
transplantation, in order to provide human recipients of these future
transplants the greatest safety and efficiency possible.
Conclusions
In the animals with immunosupression with cyclosporine
subjected to allograft of pancreatic islets prepared with the
mechanical-enzymatic preparation method (stationary collagenase
digestion and purification with dextran discontinuous density
gradient), the production of insulin is decreased and the response
to intravenous glucose is altered.
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